Nasdaq
APRE
Aprea Therapeutics, Inc.
- Health Care
- Listed 2019
- 1 day
- +1.9%
- 1 month
- −17.8%
- 1 year
- −61.4%
$0.6325 · Mkt cap $7.83M
At the 6 Aug 2026 close
Nasdaq
Aprea Therapeutics, Inc.
$0.6325 · Mkt cap $7.83M
At the 6 Aug 2026 close
Aprea Therapeutics, Inc. trades under the ticker APRE on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2019. Its market capitalisation is $7.83M. The last closing price was $0.6325, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is −61.4%, and −17.8% over the past month. Returns are price returns and exclude dividends.
This page exists because APRE is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.